MedPath

四川康特能药业有限公司

Ownership
-
Established
2002-09-04
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

54

NMPA:54

Drug Approvals

去感热口服液

Product Name
奇纯
Approval Number
国药准字Z20080189
Approval Date
Jun 6, 2023
NMPA

Benzyl Alcohol Injection

Product Name
苯甲醇注射液
Approval Number
国药准字H51022493
Approval Date
Jun 23, 2021
NMPA

Cerebroprotein Hydrolysate Injection

Product Name
脑蛋白水解物注射液
Approval Number
国药准字H51023472
Approval Date
Jun 23, 2021
NMPA

Kanamycin Sulfate Injection

Product Name
硫酸卡那霉素注射液
Approval Number
国药准字H51020337
Approval Date
Jun 23, 2021
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H51022539
Approval Date
Jun 23, 2021
NMPA

Lincomycin Hydrochloride Injection

Product Name
盐酸林可霉素注射液
Approval Number
国药准字H51023974
Approval Date
Jun 23, 2021
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H51020340
Approval Date
Jun 23, 2021
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H51020341
Approval Date
Jun 23, 2021
NMPA

柴胡注射液

Approval Number
国药准字Z51020181
Approval Date
Jun 23, 2021
NMPA

Cerebroprotein Hydrolysate Injection

Product Name
脑蛋白水解物注射液
Approval Number
国药准字H51023473
Approval Date
Jun 23, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.